Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)
Clinical trial NCT05164055 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05164055
- Sponsor
- Genzyme, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2026-09-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.